 |
|
Percutaneous Transluminal Angioplasty
Council on Scientific Affairs
JAMA. 1984;251(6):764-768.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
BECAUSE the technique of percutaneous transluminal angioplasty (PTA) has therapeutic potential and is of increasing interest to physicians,1-3 the American Medical Association's Council on Scientific Affairs, in December 1981, established a panel to review medical knowledge about this new technique and to assess experience with it to date. The Council requested that the panel report on the therapeutic use of PTA in the iliofemoral, coronary, and renal artery beds. The panel's report follows.
PTA—The Procedure
The main principle of PTA is the same, whether the procedure is used in the iliofemoral, renal, or coronary artery bed.2 A double-lumen dilation catheter, with a strong, nonelastic balloon made of polyvinyl chloride or polyethylene annealed to the tip, is introduced into a mainstream vessel, either directly through the skin or by cutdown. Then the catheter is guided to the site of the lesion and positioned so that the balloon segment lies
. . . [Full Text PDF of this Article]
Author Affiliations
From the Council on Scientific Affairs, Division of Scientific Activities, American Medical Association, Chicago.
Footnotes
Report H of the Council on Scientific Affairs, adopted by the House of Delegates of the American Medical Association at the 1982 Interim Meeting.
This report is not intended to serve as a standard of medical care; standards of medical care that are determined locally and are constantly subject to change are established on the basis of all the several factors of the individual case.
Reprint requests to the Division of Scientific Activities, Council on Scientific Affairs, American Medical Association, 535 N Dearborn St, Chicago, IL 60610 (Richard J. Jones, MD).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
